Dr. Ivor Elrifi is the chair of Cooley's global patent counseling and prosecution practice group. He advises pharmaceutical, biotechnology, life sciences and medical device companies, research institutions, universities, hospitals and governments throughout the world, particularly in the US and Europe. His practice includes patent prosecution, litigation, arbitration, licensing and transactional work with a focus on novel therapeutic treatments, biotechnology, genetics, diagnostics, biomarkers, drug formulations and medical devices.

Download full bio 


  • Flexion Therapeutics Agrees to Sell to Pacira BioSciences 

  • Exscientia – $510.4 Million IPO 

  • Ovid - $75 Million IPO 

  • Reata Pharmaceuticals – $505 Million Follow-On Offering 

  • Vir Biotechnology - $143 Million IPO 

  • View all

Patent Strategy & Management Attorney of the Year – LMG Life Sciences, 2019

  • Osgoode Hall Law School
    JD, 1989

  • Queen's University
    PhD, Biology, 1986

  • Queen's University
    BS, Biology

Admissions & Credentials



New York

Ontario, Canada

United States Patent & Trademark Office

Rankings & Accolades

    Chambers: Leading Patent and Life Sciences Lawyer

    Euromoney: Global Leader in Patent Law

    IAM Patent 1000: Leading Patent Lawyer

    Legal 500: Leading Lawyer for Patent Prosecution and Healthcare

    LMG Life Sciences: "Patent Strategy and Management Attorney of the Year" and Life Sciences Star

    Managing Intellectual Property: IP Star

    Super Lawyers: Top IP Lawyer